PL3743086T3 - Kompozycje zawierające szczepy bakteryjne - Google Patents

Kompozycje zawierające szczepy bakteryjne

Info

Publication number: PL3743086T3
Authority: PL; Poland
Prior art keywords: compositions; bacterial strains; strains; bacterial
Prior art date: 2018-05-11

Application number

PL19725068T

Other languages

English (en)

Inventor

Imke Elisabeth MULDER

Parthena FOTIADOU

Amy Beth HOLT

Suaad AHMED

Anna ETTORRE

Samantha YUILLE

Ted DINAN

John CRYAN

Original Assignee

4D Pharma Research Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-05-11

Filing date

2019-05-13

Publication date

2022-06-20

2018-06-25 Priority claimed from GBGB1810386.1A external-priority patent/GB201810386D0/en

2018-08-17 Priority claimed from GBGB1813460.1A external-priority patent/GB201813460D0/en

2018-10-29 Priority claimed from GBGB1817642.0A external-priority patent/GB201817642D0/en

2018-12-12 Priority claimed from GBGB1820256.4A external-priority patent/GB201820256D0/en

2018-12-12 Priority claimed from GBGB1820264.8A external-priority patent/GB201820264D0/en

2019-05-13 Application filed by 4D Pharma Research Limited filed Critical 4D Pharma Research Limited

2022-06-20 Publication of PL3743086T3 publication Critical patent/PL3743086T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Pediatric Medicine (AREA)
Transplantation (AREA)
Physiology (AREA)
Tropical Medicine & Parasitology (AREA)

PL19725068T 2018-05-11 2019-05-13 Kompozycje zawierające szczepy bakteryjne PL3743086T3 (pl)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
EP18171893		2018-05-11
EP18178136		2018-06-15
GBGB1810386.1A GB201810386D0 (en)	2018-06-25	2018-06-25	Compositions comprising bacterial strains
GBGB1813460.1A GB201813460D0 (en)	2018-08-17	2018-08-17	Compositions comprising bacterial strains
GBGB1817642.0A GB201817642D0 (en)	2018-10-29	2018-10-29	Compositions comprising bacterial strains
GBGB1820256.4A GB201820256D0 (en)	2018-12-12	2018-12-12	Compositions comprising bacterial strains
GBGB1820264.8A GB201820264D0 (en)	2018-12-12	2018-12-12	Compositions comprising bacterial strains
EP19725068.1A EP3743086B1 (en)	2018-05-11	2019-05-13	Compositions comprising bacterial strains
PCT/EP2019/062238 WO2019215346A1 (en)	2018-05-11	2019-05-13	Compositions comprising bacterial strains

Publications (1)

Publication Number	Publication Date
PL3743086T3 true PL3743086T3 (pl)	2022-06-20

Family

ID=66597549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL19725068T PL3743086T3 (pl)	2018-05-11	2019-05-13	Kompozycje zawierające szczepy bakteryjne

Country Status (23)

Country	Link
US (3)	US11419902B2 (pl)
EP (4)	EP4056192A1 (pl)
JP (3)	JP7058449B2 (pl)
KR (2)	KR20210008391A (pl)
CN (2)	CN112512539A (pl)
AU (3)	AU2019267170A1 (pl)
BR (1)	BR112020022833A2 (pl)
CA (2)	CA3098971A1 (pl)
CY (1)	CY1125211T1 (pl)
DK (1)	DK3743086T3 (pl)
ES (1)	ES2916601T3 (pl)
HR (1)	HRP20220578T1 (pl)
IL (1)	IL278471B2 (pl)
LT (1)	LT3743086T (pl)
MD (1)	MD3743086T2 (pl)
MX (1)	MX2020012061A (pl)
PL (1)	PL3743086T3 (pl)
RS (1)	RS63273B1 (pl)
SG (2)	SG11202011028SA (pl)
SI (1)	SI3743086T1 (pl)
SM (1)	SMT202200217T1 (pl)
TW (2)	TW202014513A (pl)
WO (2)	WO2019215345A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2019009071A (es)	2017-01-31	2019-11-12	Univ Kansas State	Celulas microbianas, metodos para producir las mismas, y usos de las mismas.
SMT202000555T1 (it)	2017-06-14	2020-11-10	4D Pharma Res Limited	Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
EP3697220A4 (en)	2017-10-20	2021-08-11	MS Biotech, Inc.	PROCESS FOR PRODUCING SILAGED PLANT MATERIAL USING MEGASPHAERA ELSDENII
PL3743086T3 (pl)	2018-05-11	2022-06-20	4D Pharma Research Limited	Kompozycje zawierające szczepy bakteryjne
US11541105B2 (en)	2018-06-01	2023-01-03	The Research Foundation For The State University Of New York	Compositions and methods for disrupting biofilm formation and maintenance
JP2022511975A (ja) *	2018-12-12	2022-02-01	フォーディーファーマリサーチリミテッド	細菌株を含む組成物
TW202038979A (zh) *	2018-12-12	2020-11-01	英商4D製藥研究有限公司	包含細菌菌株之組成物
WO2021252861A1 (en) *	2020-06-11	2021-12-16	Evelo Biosciences, Inc.	Compositions and methods for treating diseases and disorders using megasphaera sp
CN112877275B (zh) *	2021-02-04	2023-03-31	中国农业科学院兰州兽医研究所	Hdac2基因敲除的bhk-21细胞系及其构建方法和应用
CN112980878B (zh) *	2021-02-04	2023-03-31	中国农业科学院兰州兽医研究所	Hdac8基因敲除的bhk-21细胞系及其构建方法和应用
EP4520816A1 (en)	2022-04-28	2025-03-12	Moon (Guangzhou) Biotech Co., Ltd.	Pharmaceutical composition, megasphaera, and use thereof
EP4516892A1 (en)	2022-04-28	2025-03-05	Moon (Guangzhou) Biotech Co., Ltd.	Pharmaceutical composition, megasphaera, and use thereof
KR102551061B1 (ko) *	2022-05-26	2023-07-03	중앙대학교 산학협력단	Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물
CN117018036B (zh) *	2023-07-28	2025-09-05	深圳未知君生物科技有限公司	巨球形菌属细菌在制备治疗癌症的药物中的应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5557520A (en) *	1978-10-26	1980-04-28	Nisshin Flour Milling Co Ltd	Preparation of carcinostatic substance
EP1389464A4 (en)	2001-04-06	2005-06-22	Combi Co	COMPOSITIONS WITH A BACTERIUM THAT MAY CONVERT MILKYLIC ACID TO BUTTERIC ACID, AND METHOD FOR THE PREVENTION / TREATMENT OF HYPERLACTACIDEMIA IN CARCINOMA IN DIGESTIVE TRAIN AND COLON USING THESE COMPOSITIONS
GB0127916D0 (en)	2001-11-21	2002-01-16	Rowett Res Inst	Method
US20040005304A1 (en)	2002-07-08	2004-01-08	Mak Wood, Inc.	Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
GB0307026D0 (en) *	2003-03-27	2003-04-30	Rowett Res Inst	Bacterial supplement
CN102349927A (zh)	2003-08-29	2012-02-15	Hdac默克研究有限责任公司	联合治疗癌症的方法
GB201112091D0 (en)	2011-07-14	2011-08-31	Gt Biolog Ltd	Bacterial strains isolated from pigs
GB201117313D0 (en)	2011-10-07	2011-11-16	Gt Biolog Ltd	Bacterium for use in medicine
SG11201503966PA (en)	2012-11-23	2015-06-29	Seres Health Inc	Synergistic bacterial compositions and methods of production and use thereof
US10973861B2 (en)	2013-02-04	2021-04-13	Seres Therapeutics, Inc.	Compositions and methods
GB201306536D0 (en)	2013-04-10	2013-05-22	Gt Biolog Ltd	Polypeptide and immune modulation
WO2015010096A1 (en) *	2013-07-18	2015-01-22	Baylor College Of Medicine	Method of enhancing potency of immune cells
CN104415060A (zh) *	2013-08-30	2015-03-18	深圳华大基因科技有限公司	可食用组合物及其制备方法和用途
US10203329B2 (en) *	2013-09-12	2019-02-12	The Johns Hopkins University	Biofilm formation to define risk for colon cancer
CN105979952B (zh)	2013-11-25	2022-04-08	赛里斯治疗公司	协同细菌组合物以及其制造方法和用途
US9650654B2 (en) *	2014-06-25	2017-05-16	William Marsh Rice University	Making C4+ products in bacteria
US10366793B2 (en) *	2014-10-21	2019-07-30	uBiome, Inc.	Method and system for characterizing microorganism-related conditions
WO2016073381A1 (en) *	2014-11-03	2016-05-12	Cerus Corporation	Compositions and methods for improved car-t cell therapies
MA41020A (fr) *	2014-11-25	2017-10-03	Evelo Biosciences Inc	Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10231941B2 (en) *	2015-01-23	2019-03-19	Temple University—Of The Commonwealth System of Higher Educaton	Use of short chain fatty acids in cancer prevention
WO2016149449A1 (en)	2015-03-18	2016-09-22	Tufts University	Compositions and methods for preventing colorectal cancer
MA41060B1 (fr)	2015-06-15	2019-11-29	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
CN108513545B (zh) *	2015-11-20	2020-11-03	4D制药研究有限公司	包含细菌菌株的组合物
PL3380108T3 (pl) *	2015-11-24	2023-03-27	Seres Therapeutics, Inc.	Zaprojektowane kompozycje bakteryjne
WO2017122197A1 (en) *	2016-01-11	2017-07-20	3Plw Ltd.	Lactic acid-utilizing bacteria genetically modified to secrete polysaccharide-degrading enzymes
CN107028985A (zh) *	2016-02-04	2017-08-11	深圳华大基因研究院	厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
WO2017172894A2 (en) *	2016-03-30	2017-10-05	The Trustees Of Columbia University In The City Of New York	Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria
US9999641B2 (en) *	2016-06-14	2018-06-19	Vedanta Biosciences, Inc.	Treatment of clostridium difficile infection
KR102708641B1 (ko) *	2016-09-27	2024-09-24	더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템	미생물유전체를 조정함으로써 면역 체크포인트 차단 요법을 증강시키는 방법
WO2018094190A2 (en)	2016-11-18	2018-05-24	Sanford Burnham Prebys Medical Discovery Institute	Gut microbiota and treatment of cancer
US20190314427A1 (en)	2016-12-16	2019-10-17	Evelo Biosciences, Inc.	Methods of treating cancer using parabacteroides
WO2018112365A2 (en)	2016-12-16	2018-06-21	Evelo Biosciences, Inc.	Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
CA3066189A1 (en) *	2017-06-14	2018-12-20	4D Pharma Research Limited	Compositions comprising bacterial strains
SMT202000555T1 (it) *	2017-06-14	2020-11-10	4D Pharma Res Limited	Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
PL3743086T3 (pl) *	2018-05-11	2022-06-20	4D Pharma Research Limited	Kompozycje zawierające szczepy bakteryjne
TW202038979A (zh)	2018-12-12	2020-11-01	英商4D製藥研究有限公司	包含細菌菌株之組成物
JP2022511975A (ja) *	2018-12-12	2022-02-01	フォーディーファーマリサーチリミテッド	細菌株を含む組成物

2019
- 2019-05-13 PL PL19725068T patent/PL3743086T3/pl unknown
- 2019-05-13 SI SI201930216T patent/SI3743086T1/sl unknown
- 2019-05-13 EP EP22162255.8A patent/EP4056192A1/en active Pending
- 2019-05-13 AU AU2019267170A patent/AU2019267170A1/en not_active Abandoned
- 2019-05-13 JP JP2020545563A patent/JP7058449B2/ja not_active Expired - Fee Related
- 2019-05-13 WO PCT/EP2019/062236 patent/WO2019215345A1/en not_active Ceased
- 2019-05-13 SG SG11202011028SA patent/SG11202011028SA/en unknown
- 2019-05-13 CN CN201980031512.5A patent/CN112512539A/zh active Pending
- 2019-05-13 EP EP19725067.3A patent/EP3790564A1/en not_active Withdrawn
- 2019-05-13 MX MX2020012061A patent/MX2020012061A/es unknown
- 2019-05-13 EP EP22162425.7A patent/EP4066845A1/en active Pending
- 2019-05-13 DK DK19725068.1T patent/DK3743086T3/da active
- 2019-05-13 KR KR1020207035242A patent/KR20210008391A/ko not_active Ceased
- 2019-05-13 BR BR112020022833-8A patent/BR112020022833A2/pt not_active IP Right Cessation
- 2019-05-13 SG SG11202011031UA patent/SG11202011031UA/en unknown
- 2019-05-13 HR HRP20220578TT patent/HRP20220578T1/hr unknown
- 2019-05-13 TW TW108116449A patent/TW202014513A/zh unknown
- 2019-05-13 LT LTEPPCT/EP2019/062238T patent/LT3743086T/lt unknown
- 2019-05-13 JP JP2020562128A patent/JP2021523895A/ja active Pending
- 2019-05-13 EP EP19725068.1A patent/EP3743086B1/en active Active
- 2019-05-13 RS RS20220465A patent/RS63273B1/sr unknown
- 2019-05-13 AU AU2019267171A patent/AU2019267171A1/en not_active Abandoned
- 2019-05-13 SM SM20220217T patent/SMT202200217T1/it unknown
- 2019-05-13 KR KR1020207035244A patent/KR20210008393A/ko not_active Ceased
- 2019-05-13 CN CN201980031147.8A patent/CN112601534A/zh active Pending
- 2019-05-13 CA CA3098971A patent/CA3098971A1/en active Pending
- 2019-05-13 WO PCT/EP2019/062238 patent/WO2019215346A1/en not_active Ceased
- 2019-05-13 ES ES19725068T patent/ES2916601T3/es active Active
- 2019-05-13 TW TW108116469A patent/TW202011975A/zh unknown
- 2019-05-13 CA CA3099209A patent/CA3099209A1/en active Pending
- 2019-05-13 MD MDE20201221T patent/MD3743086T2/ro not_active IP Right Cessation
2020
- 2020-09-04 US US17/013,026 patent/US11419902B2/en active Active
- 2020-11-03 IL IL278471A patent/IL278471B2/en unknown
- 2020-11-11 US US17/095,427 patent/US20210275605A1/en not_active Abandoned
2022
- 2022-04-05 JP JP2022062741A patent/JP2022088631A/ja active Pending
- 2022-05-27 CY CY20221100367T patent/CY1125211T1/el unknown
- 2022-06-23 US US17/847,336 patent/US20230158083A1/en not_active Abandoned
2023
- 2023-02-03 AU AU2023200562A patent/AU2023200562A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US11419902B2 (en)	2022-08-23
CA3098971A1 (en)	2019-11-14
US20230158083A1 (en)	2023-05-25
CA3099209A1 (en)	2019-11-14
AU2019267170A1 (en)	2021-01-07
JP2022088631A (ja)	2022-06-14
JP2021517560A (ja)	2021-07-26
BR112020022833A2 (pt)	2021-02-02
AU2023200562A1 (en)	2023-03-02
EP3743086B1 (en)	2022-03-16
CN112512539A (zh)	2021-03-16
LT3743086T (lt)	2022-06-10
HRP20220578T1 (hr)	2022-09-16
EP3790564A1 (en)	2021-03-17
CY1125211T1 (el)	2024-02-16
ES2916601T3 (es)	2022-07-04
IL278471A (pl)	2020-12-31
KR20210008391A (ko)	2021-01-21
KR20210008393A (ko)	2021-01-21
DK3743086T3 (da)	2022-05-02
AU2019267171A1 (en)	2021-01-07
CN112601534A (zh)	2021-04-02
SMT202200217T1 (it)	2022-07-21
WO2019215345A1 (en)	2019-11-14
EP4056192A1 (en)	2022-09-14
JP7058449B2 (ja)	2022-04-22
SG11202011028SA (en)	2020-12-30
EP3743086A1 (en)	2020-12-02
IL278471B1 (en)	2023-04-01
SI3743086T1 (sl)	2022-05-31
JP2021523895A (ja)	2021-09-09
EP4066845A1 (en)	2022-10-05
WO2019215346A1 (en)	2019-11-14
MX2020012061A (es)	2022-10-13
US20210275605A1 (en)	2021-09-09
MD3743086T2 (ro)	2022-12-31
TW202011975A (zh)	2020-04-01
US20210052671A1 (en)	2021-02-25
TW202014513A (zh)	2020-04-16
SG11202011031UA (en)	2020-12-30
RS63273B1 (sr)	2022-06-30
IL278471B2 (en)	2023-08-01

Publication	Publication Date	Title
IL283751A (en)	2021-07-29	Compositions comprising bacterial strains
SG11202011031UA (en)	2020-12-30	Compositions comprising bacterial strains
IL277422A (en)	2020-11-30	compounds containing bacterial strains
IL279963A (en)	2021-03-01	compounds containing bacterial strains
IL281951A (en)	2021-05-31	compounds containing bacterial strains
IL280895A (en)	2021-04-29	compounds containing bacterial strains
IL279339A (en)	2021-01-31	compounds containing bacterial strains
IL279724B (en)	2022-05-01	compounds containing bacterial strains
SG11202104258TA (en)	2021-05-28	Compositions comprising bacterial strains
PT3723777T (pt)	2021-06-21	Composições que compreendem estirpes bacterianas
PT3743086T (pt)	2022-05-25	Composições compreendendo estirpes bacterianas
GB201820744D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820745D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820261D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820256D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201820230D0 (en)	2019-01-23	Compositions comprising bacterial strains
GB201820264D0 (en)	2019-01-30	Compositions comprising bacterial strains
GB201817642D0 (en)	2018-12-12	Compositions comprising bacterial strains
GB201817648D0 (en)	2018-12-12	Compositions comprising bacterial strains
GB201817641D0 (en)	2018-12-12	Compositions comprising bacterial strains
GB201814836D0 (en)	2018-10-24	Compositions comprising bacterial strains
GB201813460D0 (en)	2018-10-03	Compositions comprising bacterial strains
GB201813423D0 (en)	2018-10-03	Compositions comprising bacterial strains
GB201812378D0 (en)	2018-09-12	Compositions comprising bacterial strains
GB201811900D0 (en)	2018-09-05	Compositions comprising bacterial strains